Get the full Coinpanion company profile
Access contacts, investors, buying signals & more
Coinpanion, the alternative investment platform now operating under the Altify brand, has secured $3.7M in seed funding. The capital infusion arrives as Altify aims to broaden access to lucrative alternative asset classes, particularly crypto, for a wider audience.
The integration of Coinpanion into Altify is set to enhance the platform's offerings, promising users a wider selection of investment opportunities, lower fees, and better prices, all while striving for an improved user experience.
Portfolio company of Companisto Investor Network
Epitome Therapeutics
Epitome Therapeutics is a biotechnology company advancing precision epigenome editing for programmable gene expression. Founded in 2025 as a spin-off from EMBL, Epitome is developing CADENCE, a next-generation platform designed to enable the precise and durable calibration of gene dosage without altering the underlying DNA sequence. The company aims to establish new therapeutic approaches for diseases driven by dysregulated gene activity, including rare and metabolic disorders.
$2.3M Pre-seed
23 days ago
Loom Ventures
We invest in European early-stage companies that make infrastructure more autonomous, capable, and resilient. STRABAG, one of Europe's largest infrastructure groups, is our investor and partner. This gives us and our founders direct industry access and domain expertise.
$108.0M Unknown
24 days ago
Largest funding rounds in FinTech on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Access Bank Plc Nigeria | Unknown | $100.0B | 1y ago |
| 2 |  Klarna Sweden | Unknown | $45.6B |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Clarity Systems United States | Seed | $4.4M | today |
| 2 |  Aisot Technologies Switzerland | Seed | $2.5M | today |
Mobius Bio
Mobius is a discovery stage biotech utilising a unique, clinically validated platform to identify and develop novel anticancer drugs. Our vision is to systematically go beyond the mouse and discover molecules rooted in a deep understanding of human biology, not animal models, to deliver medicines designed to succeed in the clinic. We do this by integrating frontier AI capabilities, deep disease insights and a proprietary wet lab platform, which allows us to interrogate disease mechanisms directly in live human tissue samples with proven clinical relevance. We are an international team of dedicated drug hunters, engineers and entrepreneurs determined to bring transformative treatments to patients with high unmet medical needs.
$30.0M Unknown
26 days ago
| 1y ago |
| 3 |  NatWest Group United Kingdom | Unknown | 拢23.4B | 1y ago |
| 4 |  Finitt by Fintranxect India | Series a | $7.0B | 1y ago |
| 5 |  Groww India | Seed | $5.8B | 8mo ago |
| 3 |
 DIMENSION United States |
| Seed |
| $1.6M |
| today |
| 4 |  Dimension Studios United States | Seed | $1.6M | today |
| 5 |  Demand AI United States | Seed | $6.3M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Coinpanion and reach their contacts directly.
Start free trialUnlock 8 more key decision-makers at Coinpanion with verified emails and LinkedIn.
Start free trial
adviice.ca
Recently received
Tap Invest
Recently received
Vertis SGR
Recently received
